Pilot clinical study of Sasa senanensis rehder leaf extract treatment on lichenoid dysplasia

In Vivo

Volumn 26, Issue 6, 2012, Pages 957-962

  Matsuta, Tomohiko ^a   Sakagami, Hiroshi ^a   Tanaka, Shoji ^a   Machino, Mamoru ^a   Tomomura, Mineko ^a   Tomomura, Akito ^a   Yasui, Toshikazu ^a   Itoh, Kazuyoshi ^b   Sugiura, Tomoko ^c   Kitajima, Madoka ^c   Oizumi, Hiroshi ^c   Oizumi, Takaaki ^c  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b Taihei Bill Service Co Itd   (Japan)

^c Daiwa Biological Research Institute Co Ltd   (Japan)

Author keywords

IL 6; IL 8; Lichenoid displasia; Osteoclastogenesis; Saliva; Sasa senanensis Rehder extract

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; INTERLEUKIN 6; INTERLEUKIN 8; OSTEOCLAST DIFFERENTIATION FACTOR; PLANT EXTRACT; SASA SENANENSIS REHDER LEAF EXTRACT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; DRUG POTENCY; DYSPLASIA; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LICHENOID; MACROPHAGE; MALE; MOUTH EXAMINATION; MOUTH MUCOSA; MULTINUCLEAR CELL; OSTEOCLAST; OSTEOCLASTOGENESIS; PHOTOGRAPHY; PILOT STUDY; PLANT LEAF; PROTEIN ANALYSIS; SALIVA ANALYSIS; SASA; SASA SENANENSIS; TREATMENT DURATION;

EID: 84872181209     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. The Pharmaceutical Affairs Law in Japan, Pharmaceuticals and Medical Safety Bureau, Ministry of Health, Labour and Welfare, Tokyo, 2009.
2. Chuyen NY, Kurata T and Kato H: Antiseptic activity of Sasa senanensis Rehder extract. J Antibac Antifung Agents 11: 69-75, 1983 (in Japanese).
3. Ohizumi T, Kodama K, Tsuji M and Oguchi K: The effect of Sasa senanensis Rehder extract and crude herb medicine extract on the membrane. Showa Med J 49: 315-321, 1989 (in Japanese).
4. Ohizumi T, Shirasaki K, Tabata T, Nakayama S, Okazaki M and Sakamoto K: Pharmacological studies of Sasa senanensis Rehder extract on anti-inflammatory effect and phagocytic activity. Showa Med J 48: 595-600, 1988 (in Japanese).
5. 2 production by activated mouse macrophage-like RAW264.7 cells. In Vivo 23: 773-778, 2009.
6. Ono M, Kantoh K, Ueki J, Shimada A, Wakabayashi H, Matsuta T, Sakagami H, Kumada H, Hamada N, Kitajima M, Oizumi H and Oizumi T: Quest for anti-inflammatory substances using IL-1β-stimulated gingival fibroblasts. In Vivo 25: 763-768, 2011.
7. Sakagami H, Amano S, Kikuchi H, Nakamura Y, Kuroshita R, Watanabe S, Satoh K, Hasegawa H, Nomura A, Kanamoto T, Terakubo S, Nakashima H, Taniguchi S and Ohizumi T: Antiviral, antibacterial and vitamin C-synergized radical scavenging activity of Sasa senanensis Rehder extract. In Vivo 22: 471-476, 2008.
8. Sakagami H, Zhou Li, Kawano M, Thet MM, Takana S, Machino M, Amano S, Kuroshita R, Watanabe S, Chu Q, Wang QT, Kanamoto T, Terakubo S, Nakashima H, Sekine K, Shirataki Y, Hao ZC, Uesawa Y, Mohri K, Kitajima M, Oizumi H and Oizumi T: Multiple biological complex of alkaline extract of the leaves of Sasa senanensis Rehder. In Vivo 24: 735-744, 2010.
9. Matsuta T, Sakagami H, Kitajima M, Oizumi H and Oizumi T: Anti-UV activity of alkaline extracts of the leaves of Sasa senanensis Rehder. In Vivo 25: 751-755, 2011.
10. Matsuta T, Sakagami H, Satoh K, Kanamoto T, Terakubo S, Nakashima H, Kitajima M, Oizumi H and Oizumi T: Biological activity of luteolin glycosides and tricin from Sasa senanensis Rehder. In Vivo 25: 757-762, 2011.
11. Komatsu M and Hiramatsu M: Free radical scavenging activity of Sasa senanensis Rehder extract. Kiso To Rinsho 31: 3321-3324, 1997 (in Japanese).
12. Sakagami H, Kushida T, Oizumi T, Nakashima H and Makino T: Distribution of lignin-carbohydrate complex in the plant kingdom and its functionality as alternative medicine. Pharmacol Ther 128: 91-105, 2010.
13. Sakagami H, Iwamoto S, Matsuta T, Satoh K, Shimada C, Kanamoto T, Terakubo S, Nakashima H, Morita Y, Ohkubo A, Tsuda T, Sunaga K, Kitajima M, Oizumi H and Oizumi T: Comparative study of biological activity of three commercial products of Sasa senanensis Rehder leaf extract. In Vivo 26: 259-264, 2012.
14. López BSG, Yamamoto M, Utsumi K, Aratsu C and Sakagami H: Clinical pilot study of lignin-ascorbic acid combination treatment of herpes simplex virus. In Vivo 23: 1011-1016, 2009.
15. López BSG, Yamamoto M and Sakagami H: Chapter 9. Treatment of herpes simplex virus with lignin-carbohydrate complex tablet, an alternative therapeutic formula. In: Antiviral Drugs - Aspects of Clinical Use and Recent Advances, Arbuthnot P (ed). InTech, Croatia, pp. 171-194.
16. Cervoni E: Hepatitis C. Lancet 351: 1209-1210, 1998.
17. Nagao Y, Sata M, Tanikawa K, Itoh K and Kameyama T: High prevalence of hepatitis C virus antibody and RNA in patients with oral cancer. J Oral Pathol Med 24: 354-360, 1995.
18. Nagao Y and Sata M: High incidence of multiple primary carcinomas in HCV-infected patients with oral squamous cell carcinoma. Med Sci Monit 15: 453-459, 2009.
19. Sand LP, Jalouli J, Larsson PA and Hirsch JM: Prevalence of Epstein-Barr virus in oral squamous cell carcinoma, oral lichen planus, and normal oral mucosa, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93: 586-592, 2002.
20. Babizhayev MA, Deyev AI, Macrophage of the virulent influenza virus infection by oral formation of nonhydrolized carnosine and isopeptide of carnosine attenuating proinflammatory cytokine-induced nitric oxide production. Am J Therap 15: 25-47, 2012.
21. Bondeson J: The mechanisms of action of disease-modifying antirheumatic drugs: A review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines. General Pharmacol 29: 127-150, 1997.
22. Jiang J, Li H, Fahid FS, Filbert E, Safavi KE, Spangberg LS and Zhu Q: Quantitative analysis of osteoclast-specific gene markers stimulated by lipopolysaccharide. J Endodont 32: 742-746, 2006.
23. Hasegawa H, Kido S, Tomomura M, Fujimoto K, Ohi M, Kiyomura M, Kanagae H, Inaba A, Sakagami H and Tomomura A: Serum calcium-decreasing factor, caldecrin, inhibits osteoclast differentiation by suppression of NFATc1 activity. J Biol Chem 285: 25448-25457, 2010.
24. Masuda Y, Ueda J, Tamura M, Sakagami H, Tomomura M, Tomomura A and Shirataki Y: Diverse biological activity of Odontoglossum Harvengtens 'Tutu' bulb extracts. In Vivo 25: 381-386, 2011.
25. Ishida N, Hayashi K, Hoshijima M, Ogawa T, Koga S, Miyatake Y, Kumegawa M, Kimura T and Takeya T: Large-scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem 277: 41147-41156, 2002.
26. Pavlotsky F, Nathansohn K, Kriger G, Shpiro D and Trau H: Ultraviolet-B treatment for cutaneous lichen planus: our eperience with 50 patients. Photodermatol Photoimmunol Photomed 24: 83-86, 2008.
27. Choonkakarn C, Busaracome P, Sripanidkulchai B and Sarakarn P: The efficacy of aloe vera gel in the treatment of oral lichen planus: a randomized controlled trial. Br J Dermatol 158: 573-577, 2007.
28. Agha-Hosseini F, Borhan-Mojabi K, Monsef-Esfahani HR, Mirzaii-Dizgah I, Etemad-Moghadam S and Karagah A: Efficacy of purslane in the treatment of oral lichen planus. Phytother Res 24: 240-244, 2010.
29. Kitazawa R, Kimble RB, Vannice JL, Kunq VT and Pacifici R: Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 94: 2397-2406, 1994.
30. Jilka RL, Hangoc G, Girasol G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H and Manolaqas SC: Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 257: 88-91, 1992.
31. Sugermann PB, Savage NW, Seymour GJ and Walsh LJ: Is there a role for tumor necrosis factor-α in oral lichem planus. J Oral Pathol Med 25: 219-224, 1996.
32. Nibali L, Fedele S, D'AiutoF and Donos N: Interleukin-6 in oral diseases: A review. Oral Diseases 18: 236-243, 2012.
33. Kushida T, Makino T, Tomomura M, Tomomura A and Sakagami H: Enhancement of dectin-2 gene expression by lignincarbohydrate complex from Lendinus edodes extract (LEM) in mouse macrophage-like cell line. Anticancer Res 31: 1241-1248, 2011.
34. Elwood JM, Peason JC, Skippen DH and Jackson SM: Alcohol, smoking, social and occupational factors in the etiology of cancer of the oral cavity, pharynx and larynx. Int J Cancer 3: 603-612, 1984.